As of 2026-06-26, Taysha Gene Therapies, Inc. Common Stock (TSHA) has a 3-month relative strength percentile of 89 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 72. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.9%, relative volume 3.52×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ADR% (20d)avg daily range
6.9%Elevated
ATR(14)14-day EMA
$0.42
ATR%ATR as % of close
6.70%
Beta vs SPY90d rolling
1.99
1-ADR stoprisk from close $6.34
$5.90−6.9%
COMPUTED · AS OF 2026-06-26
Pattern read
TSHA is in a stage 2 uptrend, week 2. Currently in a 35-day base; basing ADR 6.8% (broad 5.9%). VCP detected: 3 contractions. RS line below base-start high. Distance from 50d / 200d: 3.4% / 27.6%.
Pure factual computation. Not a recommendation. See stage analysis.
TSHA ranks at the 78th percentile over 1 month, 89th percentile over 3 months, 62th percentile over 6 months, 93th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
TSHA is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
TSHA currently shows a 20-day average daily range (ADR%) of 6.9%, a 90-day beta versus the S&P 500 of 1.99. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
TickerStance computes TSHA's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what TSHA has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
TSHA most recently filed a 10-Q covering FY26 Q1 with the SEC on 2026-05-06. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.
§ Seasonality
10y · since 2022
Best monthAugon averageavg +90.33% · 75% win · n 4
Worst monthJanon averageavg -18.21% · 0% win · n 4